Remove Leads Remove Networking Remove Transportation
article thumbnail

Building a Robust Provider Network with SDoH Insights

Clarify Health

When building provider networks, it is crucial to include providers who can assess and address social determinants to ensure that care is equitable, patient-centered, and effective in improving health outcomes and reducing healthcare disparities. Cost Savings: Addressing SDoH can lead to cost savings in the long run.

article thumbnail

Leading pharmaceutical logistics and pharma supply chain companies

Pharmaceutical Technology

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Unlocking the Potential of Healthcare Claims Data Part II: Optimizing Network Performance

Clarify Health

This is part two of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. That’s how healthcare networks can stay prepared without overextending their capacity.

article thumbnail

How payers can use healthcare data to enhance network adequacy

Clarify Health

Designing and maintaining a healthcare network is no simple task—especially when it comes to meeting the needs for accessibility, quality, and cost across a diverse pool of members. Health plans need to design networks that offer members reasonable access to in-network providers to ensure the network is adequate to meet their health needs.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. The significant challenges, here, lie in effectively managing the complexity and coordination among diverse interconnected networks, particularly when operating across countries with varying regulations.

article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Challenges in the pharmaceutical supply chain Pharmaceutical supply chain issues include long transportation distances, low transparency of inventory levels and cargo theft. These can lead to inventory shortages, the paper noted.

article thumbnail

BioNTech to buy UK-based AI company InstaDeep

Pharmaceutical Technology

The acquisition will help the company enhance its research collaborators network globally and expand its footprint in hubs across the US, Africa, Europe, and the Middle East. InstaDeep will operate as BioNTech’s UK subsidiary and lead the growing portfolio of AI and ML initiatives at BioNTech after the deal’s completion.